AHA letter to House Energy and Commerce Committee opposing Section 2123, Additional Payment for New Antimicrobial Drugs under Medicare, of the 21st Century Cures Act
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.